- Report
- February 2024
- 125 Pages
Global
From €4194EUR$4,750USD£3,640GBP
- Report
- February 2024
- 110 Pages
Global
From €4194EUR$4,750USD£3,640GBP
- Report
- February 2024
- 120 Pages
Global
From €4194EUR$4,750USD£3,640GBP
- Report
- April 2023
- 115 Pages
Global
From €4194EUR$4,750USD£3,640GBP
- Report
- January 2024
- 144 Pages
Global
From €3002EUR$3,400USD£2,605GBP
€3753EUR$4,250USD£3,256GBP
- Report
- September 2022
- 120 Pages
Global
From €2207EUR$2,500USD£1,916GBP
- Report
- February 2024
- 113 Pages
Global
From €4194EUR$4,750USD£3,640GBP
- Report
- April 2023
- 240 Pages
Global
From €3179EUR$3,600USD£2,758GBP
- Report
- April 2023
- 82 Pages
North America
From €1324EUR$1,500USD£1,149GBP
- Report
- April 2023
- 94 Pages
Africa, Middle East
From €1324EUR$1,500USD£1,149GBP
- Report
- March 2023
- 203 Pages
Global
From €3179EUR$3,600USD£2,758GBP
- Report
- March 2023
- 84 Pages
Africa, Middle East
From €1324EUR$1,500USD£1,149GBP
- Report
- March 2023
- 84 Pages
Asia Pacific
From €1324EUR$1,500USD£1,149GBP
- Report
- March 2023
- 85 Pages
Europe
From €1324EUR$1,500USD£1,149GBP
- Report
- March 2023
- 74 Pages
North America
From €1324EUR$1,500USD£1,149GBP
- Report
- November 2020
- 90 Pages
Middle East, Africa
From €3046EUR$3,450USD£2,643GBP
- Report
- May 2024
- 116 Pages
Global
From €2790EUR$3,160USD£2,421GBP
€3488EUR$3,950USD£3,027GBP
- Report
- June 2025
- 250 Pages
India
From €2463EUR$2,789USD£2,137GBP
- Report
- April 2023
- 147 Pages
Global
From €4370EUR$4,949USD£3,792GBP
- Report
- August 2022
- 111 Pages
Global
From €3973EUR$4,500USD£3,448GBP

Neuropathic pain is a type of chronic pain caused by damage to the nervous system. It is often described as a burning, tingling, or shooting sensation. Analgesics are medications used to reduce or eliminate pain. Neuropathic pain is often treated with a combination of analgesics, including non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and anticonvulsants. Other treatments may include physical therapy, nerve blocks, and electrical stimulation.
The neuropathic pain market is a rapidly growing segment of the analgesics market. It is driven by the increasing prevalence of chronic pain conditions, such as diabetes, cancer, and multiple sclerosis. The market is expected to benefit from the development of novel treatments, such as gene therapy and stem cell therapy.
Some companies in the neuropathic pain market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Eli Lilly. Show Less Read more